GENEVA, Aug. 21 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. filed a patent application (CN2026/079116) for “NOVEL TEMPERATURE UPSHIFT PROCESS FOR REDUCING LEVEL OF MAN5 GLYCOFORM IN ANTIBODY PROTEIN”. With publication no. WO/2026/171230, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 3/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....